Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineDaniel D. Von Hoff, Markus F. Renschler, Jeffrey R. Infante et al.|New England Journal of Medicine|2013Cited by 6.6k
Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapiesE. Gabriela Chiorean, Andrew L. Coveler|Drug Design Development and Therapy|2015Cited by 252
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumorsJason J. Luke, Aung Naing, Marwan Fakih et al.|British Journal of Cancer|2023Cited by 30